Skip to content

Clinical trials

Terminated Observational Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Observational Status: Terminated Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20022
20072
20082
20091
20101
20112
20141
20161
20172
20181
20201
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Mental Health (NIMH)5
Janssen-Cilag, S.A.2
Angelini Farmacéutica1
AstraZeneca1
GCS CIPS1
Hôpital NOVO1
Lundbeck Canada Inc.1
National Eye Institute (NEI)1
National Taiwan University Hospital1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia23
Psychotic Disorders10
Bipolar Disorder3
Mental Disorders3
Anxiety Disorders2
Arrhythmias, Cardiac1
Asthma1
Brain Diseases1
Coronary Disease1
Dementia1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.